Nonetheless, our study identified a role for CD93 in regulating TME, influencing clinical prognosis and immunoregulation effect, particularly immune infiltration, and expanding our understanding of CD93 biology and tissue–immune system interaction, which may lead to new treatments for inflammatory diseases and cancer. Here, CD93 is linked to cancer.